Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy C Toner

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Urologic Clinics of North America|May 9, 2007
The challenge of poor-prognosis germ cell tumorsGuy C Toner
Seminars in Urologic Oncology|December 19, 2002
Poor prognosis germ-cell tumors: An unresolved challengeGuy C Toner, Mark Frydenberg
The Oncologist|June 17, 2008
PET for sarcomas other than gastrointestinal stromal tumorsGuy C Toner, Rodney J Hicks
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 13, 2005
Clinical applications of molecular imaging in sarcoma evaluationRodney J Hicks, Guy C Toner, Peter F M Choong
International Journal of Cardiology|October 9, 2007
Apical ballooning syndrome during treatment with a vascular endothelial growth factor receptor antagonistAnthony J White, Andre LaGerche, Guy C Toner, et al.
International Seminars in Surgical Oncology : ISSO|June 2, 2005
Durable remissions are rare following high dose therapy with autologous stem cell transplantation for adults with "paediatric" bone and soft tissue sarcomasShriram V Nath, H Miles Prince, Peter Fm Choong, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2003
Hair depigmentation is a biological readout for pharmacological inhibition of KIT in mice and humansKatherine G Moss, Guy C Toner, Julie M Cherrington, et al.
American Journal of Clinical Oncology|June 1, 2002
Phase II trial of continuous infusion carboplatin, 5-fluorouracil, and radiotherapy for localized cancer of the esophagusMichael Jefford, Guy C Toner, Jennifer G Smith, et al.
Anti-Cancer Drugs|April 18, 2008
Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinomaSarah-Jane Dawson, Nelly Marmy Conus, Guy C Toner, et al.
BJU International|June 26, 2013
Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancerPeter Grimison, Baerin Houghton, Mark Chatfield, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Urologic Clinics of North America|May 9, 2007
The challenge of poor-prognosis germ cell tumorsGuy C Toner
Seminars in Urologic Oncology|December 19, 2002
Poor prognosis germ-cell tumors: An unresolved challengeGuy C Toner, Mark Frydenberg
The Oncologist|June 17, 2008
PET for sarcomas other than gastrointestinal stromal tumorsGuy C Toner, Rodney J Hicks
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 13, 2005
Clinical applications of molecular imaging in sarcoma evaluationRodney J Hicks, Guy C Toner, Peter F M Choong
International Journal of Cardiology|October 9, 2007
Apical ballooning syndrome during treatment with a vascular endothelial growth factor receptor antagonistAnthony J White, Andre LaGerche, Guy C Toner, et al.
International Seminars in Surgical Oncology : ISSO|June 2, 2005
Durable remissions are rare following high dose therapy with autologous stem cell transplantation for adults with "paediatric" bone and soft tissue sarcomasShriram V Nath, H Miles Prince, Peter Fm Choong, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2003
Hair depigmentation is a biological readout for pharmacological inhibition of KIT in mice and humansKatherine G Moss, Guy C Toner, Julie M Cherrington, et al.
American Journal of Clinical Oncology|June 1, 2002
Phase II trial of continuous infusion carboplatin, 5-fluorouracil, and radiotherapy for localized cancer of the esophagusMichael Jefford, Guy C Toner, Jennifer G Smith, et al.
Anti-Cancer Drugs|April 18, 2008
Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinomaSarah-Jane Dawson, Nelly Marmy Conus, Guy C Toner, et al.
BJU International|June 26, 2013
Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancerPeter Grimison, Baerin Houghton, Mark Chatfield, et al.
Pageof 3